Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chambers

Showing results (801-810 of 12,534) with videos related to

Pageof 1,254
Sort By:
Journal of Food Protection|April 13, 2018
Contamination by Meat Juice When Shopping for Packages of Raw PoultryFur-Chi Chen, Sandria Godwin, Delores Chambers, et al.
Gynecologic Oncology|February 1, 1995
Extramammary Paget's disease of the vulvaD A Fishman, S K Chambers, P E Schwartz, et al.
Cancer|December 15, 1989
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancerS K Chambers, R L Chopyk, J T Chambers, et al.
Toxicology Letters|August 6, 2014
Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotypeR Hunter Coombes, Edward C Meek, Mary Beth Dail, et al.
Biochemical Genetics|July 17, 2014
Paraoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibilityChiquita Y McDaniel, Mary Beth Dail, Robert W Wills, et al.
Cancer|August 1, 1987
Circulating tumor markers in the monitoring of gynecologic malignanciesP E Schwartz, S K Chambers, J T Chambers, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 12, 2002
Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failureOmer T Yalcin, Thomas J Rutherford, Setsuko K Chambers, et al.
Gynecologic Oncology|February 13, 2001
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinomaE P Toy, J T Chambers, B M Kacinski, et al.
Environmental Health Perspectives|August 13, 2009
Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?Kimberly A Davis, J Allen Crow, Howard W Chambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II studyS K Chambers, C A Davis, P E Schwartz, et al.
Pageof 1,254

Showing results (801-810 of 12,534) with videos related to

Sort By:
Pageof 1,254
Journal of Food Protection|April 13, 2018
Contamination by Meat Juice When Shopping for Packages of Raw PoultryFur-Chi Chen, Sandria Godwin, Delores Chambers, et al.
Gynecologic Oncology|February 1, 1995
Extramammary Paget's disease of the vulvaD A Fishman, S K Chambers, P E Schwartz, et al.
Cancer|December 15, 1989
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancerS K Chambers, R L Chopyk, J T Chambers, et al.
Toxicology Letters|August 6, 2014
Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotypeR Hunter Coombes, Edward C Meek, Mary Beth Dail, et al.
Biochemical Genetics|July 17, 2014
Paraoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibilityChiquita Y McDaniel, Mary Beth Dail, Robert W Wills, et al.
Cancer|August 1, 1987
Circulating tumor markers in the monitoring of gynecologic malignanciesP E Schwartz, S K Chambers, J T Chambers, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 12, 2002
Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failureOmer T Yalcin, Thomas J Rutherford, Setsuko K Chambers, et al.
Gynecologic Oncology|February 13, 2001
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinomaE P Toy, J T Chambers, B M Kacinski, et al.
Environmental Health Perspectives|August 13, 2009
Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?Kimberly A Davis, J Allen Crow, Howard W Chambers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II studyS K Chambers, C A Davis, P E Schwartz, et al.
Pageof 1,254